Metraipolis › archive › dc_063a164ed558
A human-specific RPGR isoform and a clinically approved Rho/ROCK inhibitor ameliorate defects associated with RPGR dysfunction — Europe PMC PMID:41323795
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41323795
- DOI
- 10.1016/j.omtn.2025.102758
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T22:24:06.572Z
- SHA-256 of the archived text
f89c9cdf68d24271ea077aa58af70f11adb0a75b39e6de6b9d909d3e851f882b- Stable URL of this page
https://metraipolis.com/documento/dc_063a164ed558
How to cite
A human-specific RPGR isoform and a clinically approved Rho/ROCK inhibitor ameliorate defects associated with RPGR dysfunction — Europe PMC PMID:41323795 — Europe PMC (en), https://europepmc.org/article/MED/41323795 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_063a164ed558 (Metraipolis archive dc_063a164ed558, sha256 f89c9cdf68d24271ea077aa58af70f11adb0a75b39e6de6b9d909d3e851f882b)
BibTeX
@misc{dc063a164ed558,
title = {A human-specific RPGR isoform and a clinically approved Rho/ROCK inhibitor ameliorate defects associated with RPGR dysfunction — Europe PMC PMID:41323795},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41323795},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_063a164ed558; sha256 f89c9cdf68d24271ea077aa58af70f11adb0a75b39e6de6b9d909d3e851f882b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41323795. Agents can read the archived copy with the MCP tool read_document.